GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

盘前交易 07-23 04:22:16 EDT

2.71

-0.04

-1.45%

最高2.87	最低2.69	成交量1.39万
今开2.69	昨收2.75	日振幅6.55%
总市值584.45万	流通市值493.36万	总股本215.67万
成交额3.81万	换手率0.76%	流通股本182.05万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":2.71,"timestamp":1721678400000,"preClose":2.75,"halted":0,"volume":13859,"delay":0,"floatShares":1820528,"shares":2156651,"eps":-6.775637,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.04,"latestTime":"07-23 04:22:16 EDT","open":2.69,"high":2.87,"low":2.69,"amount":38129.7289708,"amplitude":0.065455,"askPrice":3.2,"askSize":100,"bidPrice":1.09,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-6.775637,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721741400000},"adr":0,"adjPreClose":2.71,"postHourTrading":{"tag":"盘后","latestPrice":2.7,"preClose":2.71,"latestTime":"17:32 EDT","volume":140,"amount":378,"timestamp":1721683974410},"volumeRatio":1.066322998435272,"impliedVol":3.9697,"impliedVolPercentile":0.3643},"requestUrl":"/m/hq/s/GTBP","defaultTab":"news","newsList":[{"id":"2449213263","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449213263","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449213263?lang=zh_cn&edition=full","pubTime":"2024-07-06 02:03","pubTimestamp":1720202615,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日02时03分，Gt Biopharma, Inc.股票出现异动，股价急速拉升5.45%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706020335941f47c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706020335941f47c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2448548859","title":"Gt Biopharma, Inc.盘中异动 急速下跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448548859","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448548859?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013505,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Gt Biopharma, Inc.股票出现异动，股价大幅下跌5.56%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131459efc1b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131459efc1b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2448914528","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.48%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448914528","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448914528?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:15","pubTimestamp":1719846934,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时15分，Gt Biopharma, Inc.股票出现波动，股价大幅下跌5.48%。截至发稿，该股报2.68美元/股，成交量2.184万股，换手率1.01%，振幅3.53%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701231534af900ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701231534af900ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2446683653","title":"Gt Biopharma, Inc.盘中异动 股价大跌7.45%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683653","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446683653?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581462,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Gt Biopharma, Inc.股票出现异动，股价大幅跳水7.45%。截至发稿，该股报2.61美元/股，成交量6446股，换手率0.30%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131029f7137db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131029f7137db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2446517558","title":"Gt Biopharma, Inc.股价拉升20.10% 市值涨158.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446517558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446517558?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:31","pubTimestamp":1719495116,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时31分，Gt Biopharma, Inc.股票出现异动，股价快速上涨20.10%。截至发稿，该股报3.65美元/股，成交量20.8849万股，换手率9.68%，振幅5.60%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721315695de72bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721315695de72bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2446399319","title":"Gt Biopharma, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446399319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446399319?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:50","pubTimestamp":1719420656,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时50分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升5.08%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005056aef6c259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005056aef6c259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2446854841","title":"Gt Biopharma, Inc.盘中异动 股价大涨8.16%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446854841","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446854841?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:37","pubTimestamp":1719322634,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时37分，Gt Biopharma, Inc.股票出现波动，股价快速拉升8.16%。截至发稿，该股报3.18美元/股，成交量3379股，换手率0.16%，振幅4.08%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为93.22%、87.78%、59.75%，振幅较大的相关个股有Cingulate Inc.、Glycomimetics, Inc.、Unicycive Therapeutics, Inc.，振幅分别为19.77%、15.94%、14.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521371496816a27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521371496816a27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2434834121","title":"GT Biopharma Inc    预计每股亏损 2.70 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434834121","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434834121?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:01","pubTimestamp":1715338913,"startTime":"0","endTime":"0","summary":"   * GT Biopharma Inc    将于5月13日公布截至2024年3月31日的财报() 预计季度营收将保持不变。*    * LSEG的分析师平均预计GT生物制药公司每股亏损2.70美元。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 GT Biopharma Inc 的 12 个月目标价中位数为 150.00 美元，高于其上次收盘价 3.23 美元。5月10日 - 本摘要于北京时间 5 月 10 日 11:01 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","GT"],"gpt_icon":0},{"id":"2432346905","title":"Gt Biopharma, Inc.盘中异动 股价大涨9.54%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432346905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432346905?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:57","pubTimestamp":1714744632,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时57分，Gt Biopharma, Inc.股票出现波动，股价急速拉升9.54%。截至发稿，该股报3.50美元/股，成交量155股，换手率0.01%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032157127925c184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032157127925c184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VAXX","GTBP"],"gpt_icon":0},{"id":"2431869016","title":"Gt Biopharma, Inc.盘中异动 快速跳水5.83%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869016","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431869016?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:49","pubTimestamp":1714398546,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时49分，Gt Biopharma, Inc.股票出现波动，股价急速跳水5.83%。截至发稿，该股报3.15美元/股，成交量679股，换手率0.05%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429214906861ea19b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429214906861ea19b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2430878322","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430878322","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430878322?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:46","pubTimestamp":1714056360,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时46分，Gt Biopharma, Inc.股票出现波动，股价快速拉升6.30%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252246007a55b9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252246007a55b9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2429614932","title":"Gt Biopharma, Inc.盘中异动 股价大跌6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429614932","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429614932?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:44","pubTimestamp":1713897873,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时44分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫6.61%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.69%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240244337a54f540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240244337a54f540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2428345762","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.27%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345762","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428345762?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:32","pubTimestamp":1713360771,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时32分，Gt Biopharma, Inc.股票出现波动，股价急速上涨5.27%。截至发稿，该股报3.90美元/股，成交量170股，换手率0.01%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721325187e815de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721325187e815de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2427879628","title":"Gt Biopharma, Inc.盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427879628","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427879628?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:58","pubTimestamp":1713279499,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时58分，Gt Biopharma, Inc.股票出现波动，股价急速下挫5.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162258207a533067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162258207a533067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2426353187","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨6.25%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426353187","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426353187?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:10","pubTimestamp":1712931042,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日22时10分，Gt Biopharma, Inc.股票出现异动，股价急速上涨6.25%。截至发稿，该股报4.25美元/股，成交量674股，换手率0.05%，振幅2.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222104279203bde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222104279203bde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2426110674","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.15%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426110674","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426110674?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:15","pubTimestamp":1712679320,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日00时15分，Gt Biopharma, Inc.股票出现波动，股价急速拉升5.15%。截至发稿，该股报4.29美元/股，成交量1.087万股，换手率0.79%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100015207a51a98a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100015207a51a98a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2425990959","title":"Gt Biopharma, Inc.盘中异动 早盘快速拉升7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425990959","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425990959?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:30","pubTimestamp":1712583043,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时30分，Gt Biopharma, Inc.股票出现异动，股价快速拉升7.23%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213044861e3eb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213044861e3eb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","GTBP"],"gpt_icon":0},{"id":"2425859328","title":"Gt Biopharma, Inc.盘中异动 快速拉升7.28%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425859328","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425859328?lang=zh_cn&edition=full","pubTime":"2024-04-06 00:21","pubTimestamp":1712334061,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日00时21分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升7.28%。截至发稿，该股报4.68美元/股，成交量1023股，换手率0.07%，振幅0.69%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040600210187e23e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040600210187e23e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2424033823","title":"Gt Biopharma, Inc.盘中异动 临近午盘股价大涨8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424033823","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424033823?lang=zh_cn&edition=full","pubTime":"2024-04-03 23:36","pubTimestamp":1712158565,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日23时36分，Gt Biopharma, Inc.股票出现异动，股价大幅拉升8.10%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为486.44%、440.81%、63.93%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进，振幅分别为97.51%、58.48%、44.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032336067a50fba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032336067a50fba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2422981566","title":"GT Biopharma Inc    预计每股亏损 2.70 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422981566","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422981566?lang=zh_cn&edition=full","pubTime":"2024-03-26 19:02","pubTimestamp":1711450971,"startTime":"0","endTime":"0","summary":"   * GT Biopharma Inc    预计在3月28日发布业绩报告时，季度营收将不会有任何变化(预计)，截至2023年12月31日。*    * LSEG分析师对GT生物制药公司的平均预期是每股亏损2.70美元。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 GT Biopharma Inc 的 12 个月目标价中位数为 150.00 美元，高于其最新收盘价 4.41 美元。3月26日 - 本摘要于北京时间 3 月 26 日 11:02 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GT","GTBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0321},{"period":"1month","weight":-0.0719},{"period":"3month","weight":-0.2575},{"period":"6month","weight":-0.5894},{"period":"1year","weight":-0.6792},{"period":"ytd","weight":-0.6458}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于在使用他们的专利产品基础上开发和商业化新型免疫肿瘤产品。他们的TriKE和TetraKE平台开发出了专利性的疗法，旨在利用和增强患者自身NK细胞的癌症杀伤能力。他们正在使用TriKE和TetraKE平台，将免疫肿瘤产品推向市场，这些产品可以治疗一系列血液恶性肿瘤、肉瘤和实体肿瘤。他们还在使用这两个平台开发用于治疗传染病的治疗方法，例如用于治疗感染艾滋病毒的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.011995},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.176161},{"month":3,"riseRate":0.5,"avgChangeRate":0.060093},{"month":4,"riseRate":0.333333,"avgChangeRate":0.014218},{"month":5,"riseRate":0.571429,"avgChangeRate":0.084634},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.035324},{"month":7,"riseRate":0.285714,"avgChangeRate":0.005636},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.065921},{"month":9,"riseRate":0,"avgChangeRate":-0.169284},{"month":10,"riseRate":0.666667,"avgChangeRate":0.015149},{"month":11,"riseRate":0,"avgChangeRate":-0.211899},{"month":12,"riseRate":0.333333,"avgChangeRate":0.035421}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}